267 related articles for article (PubMed ID: 32227969)
1. Dendrimer Conjugation Enhances Tumor Penetration and Efficacy of Doxorubicin in Extracellular Matrix-Expressing 3D Lung Cancer Models.
Almuqbil RM; Heyder RS; Bielski ER; Durymanov M; Reineke JJ; da Rocha SRP
Mol Pharm; 2020 May; 17(5):1648-1662. PubMed ID: 32227969
[TBL] [Abstract][Full Text] [Related]
2. Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis.
Zhong Q; Bielski ER; Rodrigues LS; Brown MR; Reineke JJ; da Rocha SR
Mol Pharm; 2016 Jul; 13(7):2363-75. PubMed ID: 27253493
[TBL] [Abstract][Full Text] [Related]
3. Cationic poly-L-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo.
Al-Jamal KT; Al-Jamal WT; Wang JT; Rubio N; Buddle J; Gathercole D; Zloh M; Kostarelos K
ACS Nano; 2013 Mar; 7(3):1905-17. PubMed ID: 23527750
[TBL] [Abstract][Full Text] [Related]
4. The interaction of dendrimer-doxorubicin conjugates with a model pulmonary epithelium and their cosolvent-free, pseudo-solution formulations in pressurized metered-dose inhalers.
Zhong Q; Humia BV; Punjabi AR; Padilha FF; da Rocha SRP
Eur J Pharm Sci; 2017 Nov; 109():86-95. PubMed ID: 28774811
[TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine) Dendrimer-Doxorubicin Conjugates: In Vitro Characteristics and Pseudosolution Formulation in Pressurized Metered-Dose Inhalers.
Zhong Q; da Rocha SR
Mol Pharm; 2016 Mar; 13(3):1058-72. PubMed ID: 26832992
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.
Kuo PH; Teng YH; Cin AL; Han W; Huang PW; Wang LH; Chou YT; Yang JL; Tseng YL; Kao M; Chang MD
Drug Deliv; 2020 Dec; 27(1):542-555. PubMed ID: 32241176
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
8. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
9. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
10. Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.
Li N; Li N; Yi Q; Luo K; Guo C; Pan D; Gu Z
Biomaterials; 2014 Nov; 35(35):9529-45. PubMed ID: 25145854
[TBL] [Abstract][Full Text] [Related]
11. DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells.
Wang J; Li N; Cao L; Gao C; Zhang Y; Shuai Q; Xie J; Luo K; Yang J; Gu Z
J Mater Chem B; 2020 Feb; 8(6):1157-1170. PubMed ID: 31951231
[TBL] [Abstract][Full Text] [Related]
12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
13. Integrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatment.
Hu G; Zhang H; Zhang L; Ruan S; He Q; Gao H
Int J Pharm; 2015 Dec; 496(2):1057-68. PubMed ID: 26598487
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of a charge-conversional dendrimer enhances antitumor efficacy of conventional chemotherapy.
Cao J; Wang C; Guo L; Xiao Z; Liu K; Yan H
Eur J Pharm Biopharm; 2018 Jun; 127():371-377. PubMed ID: 29499301
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Peptide Amphiphile as a Drug Carrier with ATP-Triggered Release for Synergistic Effect, Improved Therapeutic Index, and Penetration of 3D Cancer Cell Spheroids.
Lu S; Zhao F; Zhang Q; Chen P
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223518
[TBL] [Abstract][Full Text] [Related]
17. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
18. Size and Surface Charge of Engineered Poly(amidoamine) Dendrimers Modulate Tumor Accumulation and Penetration: A Model Study Using Multicellular Tumor Spheroids.
Bugno J; Hsu HJ; Pearson RM; Noh H; Hong S
Mol Pharm; 2016 Jul; 13(7):2155-63. PubMed ID: 26828309
[TBL] [Abstract][Full Text] [Related]
19. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics.
Singh V; Kesharwani P
J Biomater Sci Polym Ed; 2021 Oct; 32(14):1882-1909. PubMed ID: 34078252
[TBL] [Abstract][Full Text] [Related]
20. Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model.
Kuruvilla SP; Tiruchinapally G; Crouch AC; ElSayed MEH; Greve JM
PLoS One; 2017; 12(8):e0181944. PubMed ID: 28829785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
